Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial

Abstract Background Leflunomide (LEF) is a first-line disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA). However, there are still a few nonresponders. It is logical to suggest that employing combinations including LEF that produce synergistic effects in terms of pharmacologi...

詳細記述

書誌詳細

主要な著者:	Chi Zhang, Daogang Guan, Miao Jiang, Chao Liang, Li Li, Ning Zhao, Qinglin Zha, Wandong Zhang, Cheng Lu, Ge Zhang, Jian Liu, Aiping Lu
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2019-08-01
シリーズ:	Chinese Medicine
主題:	Rheumatoid arthritis Leflunomide Ligustrazine
オンライン･アクセス:	http://link.springer.com/article/10.1186/s13020-019-0247-8
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!